Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amylin, Alkermes rally on FDA filing
By:
MarketWatch
Posted on May 05, 2009 at 10:30 AM EDT
Partners Alkermes Inc. and Amylin Pharmaceuticals rally on news that they have filed for U.S. regulatory approval for their new long-acting diabetes medication.
Read More >>
Related Stocks:
Eli Lilly & Co.
Myriad Genetics, Inc.
Novartis AG ADS
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here